http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#Head
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#assertion
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#provenance
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#pubinfo
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#assertion
http://purl.obolibrary.org/obo/DOID_1558
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_1558
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB01197
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#association
http://www.w3.org/2000/01/rdf-schema#label
"Captopril tablets are contraindicated in patients who are hypersensitive to this product or any other angiotensin-converting enzyme inhibitor (e.g., a patient who has experienced angioedema during therapy with any other ACE inhibitor). Do not co-administer aliskiren with captopril tablets in patients with diabetes (see PRECAUTIONS, Drug Interactions Captopril tablets are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer captopril tablet within 36 hours of switching to or from sacubitril/valsartan, a nepriltsin inhibitor ( see PRECAUTIONS, Drug Interactions"
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#association
https://w3id.org/biolink/vocab/relation
https://schema.org/MedicalContraindication
https://identifiers.org/drugbank:DB01197
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#provenance
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#pubinfo
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#sig
http://purl.org/nanopub/x/hasSignature
ImzXa5p4U8QDmtSTLSd1JNHNUPKD+gzbiqX3vH5URvU3okd8s5ksrDAqKBQbwbGIHLy/cJWjhDGAogc7GUtcJH2S48Eq3r/+A0UOSZhmvz/gr6NCK6XUjBwj9mMCgah/V3EIJ0/1btTBp6/qbVmjKDK48KPhrSxKgEfpQXK5J4w=
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk
http://purl.org/dc/terms/created
2021-08-23T13:05:55.070+02:00
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY